Multiple function of lncRNA MALAT1 in cancer occurrence and progression

被引：27

作者：

Malakoti, Faezeh ^{[1
,2
,3
]}

Targhazeh, Niloufar ^{[1
,2
]}

Karimzadeh, Haniye ^{[4
,5
]}

Mohammadi, Erfan ^{[6
,7
]}

Asadi, Milad ^{[7
]}

Asemi, Zatollah ^{[8
]}

Alemi, Forough ^{[1
,2
]}

机构：

[1] Tabriz Univ Med Sci, Fac Med, Dept Biochem, Tabriz, Iran

[2] Tabriz Univ Med Sci, Fac Med, Clin Labs, Tabriz, Iran

[3] Tabriz Univ Med Sci, Students Res Comm, Tabriz, Iran

[4] Isfahan Univ Med Sci, Sch Pharm, Dept Clin Biochem, Esfahan, Iran

[5] Isfahan Univ Med Sci, Isfahan Pharmaceut Sci Res Ctr, Esfahan, Iran

[6] Univ Tabriz, Fac Nat Sci, Dept Biol, Tabriz, Iran

[7] Ege Univ, Hlth Inst, Dept Basic Oncol, Izmir, Turkey

[8] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran

来源：

CHEMICAL BIOLOGY & DRUG DESIGN | 2023年 / 101卷 / 05期

关键词：

BC; COC; HCC; Lung cancer; MALAT1; miRNAs; OC; OS; LONG NONCODING RNA; HUMAN HEPATOCELLULAR-CARCINOMA; EPITHELIAL OVARIAN-CANCER; BREAST-CANCER; CELL-PROLIFERATION; CISPLATIN-RESISTANCE; SIGNALING PATHWAY; DOWN-REGULATION; REGULATES PROLIFERATION; MESENCHYMAL TRANSITION;

D O I：

10.1111/cbdd.14006

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Long non-coding RNAs (lncRNAs) have received particular attention in the last decade due to its engaging in carcinogenesis and tumorigenesis. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a lncRNA that plays physiological and pathological roles in many aspects of genome function as well as biological processes involved in cell development, differentiation, proliferation, invasion, and migration. In this article, we will review the effects of lncRNA MALAT1 on the progression of six prevalent human cancers by focusing on MALAT1 ability to regulate post-transcriptional modification and signaling pathways.

引用

页码：1113 / 1137

页数：25

共 50 条

[41] LncRNA MALAT1's role in the development of retinopathy: A review
Yang, Gukun
Huang, Xionggao
MEDICINE, 2025, 104 (12)
[42] MALAT1: a potential biomarker in cancer
Li, Zhi-Xing
Zhu, Qiong-Ni
Zhang, Hai-Bo
Hu, Yang
Wang, Guo
Zhu, Yuan-Shan
CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6757 - 6768
[43] LncRNA MALAT1 knockdown inhibits the development of choroidal neovascularization
Zhang, Xiaoli
Du, Shu
Yang, Defeng
Jin, Xuemei
Zhang, Yuan
Wang, Diya
Wang, Huixia
Zhang, Yan
Zhu, Manhui
HELIYON, 2023, 9 (09)
[44] The role of lncRNA MALAT1 in intervertebral degenerative disc disease
Zhang, Hui
Li, Jinde
Duan, Dapeng
She, Wei
Wang, Liguo
Zhang, Fuqiang
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (10): : 10611 - +
[45] LncRNA MALAT1: A potential therapeutic target in DSS-induced ulcerative colitis progression in vitro
Zhang, Baoqin
Li, Tiantian
Wang, Chao
Han, Jing
Wang, Baiqing
Sun, Guangbin
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (09) : 1871 - 1877
[46] LncRNA MALAT1/microRNA-30b axis regulates macrophage polarization and function
Ahmad, Imran
Naqvi, Raza Ali
Valverde, Araceli
Naqvi, Afsar R.
FRONTIERS IN IMMUNOLOGY, 2023, 14
[47] Finely tuned conformational dynamics regulate the protective function of the lncRNA MALAT1 triple helix
Ageeli, Abeer A.
McGovern-Gooch, Kayleigh R.
Kaminska, Magdalena M.
Baird, Nathan J.
NUCLEIC ACIDS RESEARCH, 2019, 47 (03) : 1468 - 1481
[48] TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway
Zhao, Xing
Chen, Qiuyang
Cai, Yujie
Chen, Danze
Bei, Mingrong
Dong, Hongyan
Xu, Jianzhen
JOURNAL OF CANCER, 2021, 12 (16): : 4883 - 4890
[49] Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression
Liao, Keman
Lin, Yingying
Gao, Weizhen
Xiao, Zhipeng
Medina, Rogelio
Dmitriev, Pauline
Cui, Jing
Zhuang, Zhengping
Zhao, Xiaochun
Qiu, Yongming
Zhang, Xiaohua
Ge, Jianwei
Guo, Liemei
MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 18 : 388 - 399
[50] LncRNA MALAT1 Expression Regulates Breast Cancer Progression via PI3K/AKT/mTOR Pathway Modulation
Naveed, Mariam
Malik, Ayesha
Anjum, Hamza
Ijaz, Bushra
BIOCHEMICAL GENETICS, 2024, 62 (05) : 3421 - 3438

← 1 2 3 4 5 →